Quick Answer
Bionano Genomics, Inc. reported Total Assets of $73.58 million for fiscal year 2025.
Bionano Genomics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $73.58M | -4.0% |
| 2024 | $76.67M | -64.2% |
| 2023 | $214.40M | -30.3% |
| 2022 | $307.50M | -18.5% |
| 2021 | $377.10M | +523.8% |
| 2020 | $60.45M | +100.1% |
| 2019 | $30.21M | +21.8% |
| 2018 | $24.80M | +144.5% |
| 2017 | $10.15M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $79.06M | -9.5% | +4.0% |
| June 30, 2025 | $76.01M | -41.2% | -3.1% |
| March 31, 2025 | $78.41M | -50.4% | +2.3% |
| December 31, 2024 | $76.67M | -64.2% | -12.2% |
| September 30, 2024 | $87.36M | -52.0% | -32.5% |
| June 30, 2024 | $129.36M | -52.3% | -18.1% |
| March 31, 2024 | $158.00M | -45.9% | -26.3% |
| December 31, 2023 | $214.40M | -30.3% | +17.9% |
- Bionano Genomics, Inc. showed a decrease of -4.0% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Bionano Genomics, Inc.’s total assets has grown by 625.3% (from $10.15 million to $73.58 million).
- The most recent figure is from Bionano Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: